Abstract: The present application provides a combination product for the treatment and/or prevention of psychiatric and/or neurological disorders. The combination product comprises (i) a compound which promotes neurogenesis and has hallucinogenic and/or psychedelic side effects, and (ii) a 5-HT2A receptor antagonist which alleviates and/or removes the hallucinogenic and/or psychedelic side effects caused by the first compound.

Abstract: A system and method is for personal authentication with respect to a service provider using a mobile device. The method includes providing the user of the mobile device (2) with a two-dimensional code (1), the information contained in a two-dimensional code (1) including encrypted original data which includes an encrypted session key for certifying the user with respect to the service provider; the mobile device (2) obtaining an image containing the two-dimensional code (1) via an image capturing system; the mobile device (2) obtaining the two-dimensional code (1) from the image; the two-dimensional code (1) being converted into a character code. The mobile device (2) obtains the original data including the dynamic session key for authenticating the user before the service provider from the character code, by applying a decryption process.

Abstract: Compositions and methods are provided for identifying and designing modulators of integrin-mediated cell-cell interactions through altering the interaction of ADAM 23 with &agr;v&bgr;3 integrin. Compositions and-methods are also provided for modulating integrin-mediated cell-cell interactions such as those involved in angiogenesis, induction of active metalloproteinases, tumor progression and neural tissue growth.

Abstract: Compounds having formula (I) wherein R3, R4, R7 and R8 are independently selected from the group consisting of hydrogen, lower alkyl, halogen, amine, mono(lower)alkylamine, di(lower)alkylamine, phenyl, or substituted phenyl possess antitumor activity and are new with the exception of the compound in which R3, R4, R7, R8 are all hydrogen and the compound in which R3 and R7 are hydrogen, R4 is chlorine, and R8 is a 2-nitrophenyl group.

Abstract: 1 Compounds having formula (I) wherein R3, R4, R7, and R8 are independently selected from the group consisting of hydrogen, lower alkyl, halogen, amine, mono(lower)alkylamine, di(lower)alkylamine, phenyl, or substituted phenyl possess antitumor activity and are new with the exception of the compound in which R3, R4, R7, R8 are all hydrogen and the compound in which R3 and R7 are hydrogen, R4 chlorine, and R8 is a 2-nitrophenyl group.

Abstract: Compositions and methods are provided for identifying and designing modulators of integrin-mediated cell-cell interactions through altering the interaction of ADAM 23 with &agr;v&bgr;3 integrin. Compositions and methods are also provided for modulating integrin-mediated cell-cell interactions such as those involved in angiogenesis, induction of active metalloproteinases, tumor progression and neural tissue growth.

Abstract: A double interaction switch has a case in which a single block of contactors is controlled by two levers; namely, one monostable lever and one bistable lever. The bistable lever may be locked in one of its two stable positions. When the bistable lever is so locked, the monostable lever may be moved, and actuation of the bistable lever thereafter causes it to return to its unlocked position. When the monostable lever comes back to its rest position, with the bistable lever initially locked, the bistable lever comes back to its rest position. The bistable lever is lockable by means of a rod which may pivot under the action of a labyrinth, provided on the lever. The switch is suitable for use with "hands free" telephone receiver sets.